XML 31 R21.htm IDEA: XBRL DOCUMENT v3.25.0.1
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2024
Accounting Changes and Error Corrections [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments
The impact of the restatement on the consolidated balance sheet as of June 30, 2024 is as follows (in thousands):
June 30, 2024
As ReportedAdjustmentAs Restated
(unaudited)
Assets
Accounts receivable 22,073 13,850 35,923 
Prepaid expenses and other current assets23,986 602 24,588 
Total current assets 554,470 14,452 568,922 
Total assets $826,167 $14,452 $840,619 
Liabilities and stockholders’ equity
Current liabilities
Deferred income36,472 (36,472)— 
Debt6,947 31,983 38,930 
Total current liabilities 80,076 (4,489)75,587 
Uncertain tax position payable— 8,336 8,336 
Deferred income, net of current portion104,081 (104,081)— 
Debt, net of current portion12,313 128,513 140,826 
Total liabilities 263,626 28,279 291,905 
Stockholders’ equity
Accumulated deficit (598,368)(13,827)(612,195)
Total stockholders’ equity 562,541 (13,827)548,714 
Total liabilities and stockholders’ equity $826,167 $14,452 $840,619 
The impact of the restatement on the consolidated statements of loss for the three months ended June 30, 2024 is as follows (in thousands):
Three Months Ended June 30, 2024
As ReportedAdjustmentAs Restated
Revenue
Collaborations, milestones, and royalties$16,960 $6,947 $23,907 
Loss from operations(62,317)6,947 (55,370)
Other income (expense)
Interest expense
(844)(8,438)(9,282)
Loss before income tax expense(67,291)(1,491)(68,782)
Income tax expense117 (117)— 
Net loss(67,408)(1,374)(68,782)
Net loss attributable to non-controlling interest(1,445)— (1,445)
Net loss attributable to Xencor, Inc.$(65,963)$(1,374)$(67,337)
Basic and diluted net loss per common share attributable to Xencor, Inc.$(1.07)$(0.02)$(1.09)
The impact of the restatement on the consolidated statement of loss for the six months ended June 30, 2024 is as follows (in thousands):
Six Months Ended June 30, 2024
As ReportedAdjustmentAs Restated
Revenue
Collaborations, milestones, and royalties$29,765 $10,139 $39,904 
Loss from operations(120,172)10,139 (110,033)
Other income (expense)
Interest expense(1,921)(17,037)(18,958)
Total other income (expense), net(15,828)(17,037)(32,865)
Loss before income tax expense(136,000)(6,898)(142,898)
Income tax expense117 (117)— 
Net loss(136,117)(6,781)(142,898)
Net loss attributable to non-controlling interest(2,121)— (2,121)
Net loss attributable to Xencor, Inc.$(133,996)$(6,781)$(140,777)
Basic and diluted net loss per common share attributable to Xencor, Inc.$(2.18)$(0.11)$(2.29)
The impact of the restatement on the consolidated statements of comprehensive loss for the three months ended June 30, 2024 is as follows (in thousands):
Three Months Ended June 30, 2024
As ReportedAdjustmentAs Restated
Net loss(67,408)(1,374)(68,782)
Other comprehensive loss
Net unrealized loss on marketable debt securities (498)— (498)
Comprehensive loss(67,906)(1,374)(69,280)
Comprehensive loss attributable to non-controlling interest(1,445)— (1,445)
Comprehensive loss attributable to Xencor, Inc.$(66,461)$(1,374)$(67,835)
The impact of the restatement on the consolidated statement of comprehensive loss for the six months ended June 30, 2024 is as follows (in thousands):
Six Months Ended June 30, 2024
As ReportedAdjustmentAs Restated
Net loss(136,117)(6,781)(142,898)
Other comprehensive loss
Net unrealized loss on marketable debt securities(1,942)— (1,942)
Comprehensive loss(138,059)(6,781)(144,840)
Comprehensive loss attributable to non-controlling interest(2,121)— (2,121)
Comprehensive loss attributable to Xencor, Inc.$(135,938)$(6,781)$(142,719)
The impact of the restatement on the consolidated statements of cash flows for the six months ended June 30, 2024 is as follows (in thousands):
Six Months Ended June 30, 2024
As ReportedAdjustmentAs Restated
Cash flows from operating activities
Net loss$(136,117)$(6,781)$(142,898)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash royalty revenue related to sale of future royalties— (30,855)(30,855)
Non-cash interest expense1,900 17,037 18,937 
Changes in operating assets and liabilities:
Accounts receivable
(10,783)790 (9,993)
Income taxes(5,782)(117)(5,899)
Deferred income(16,312)16,312 — 
Net cash used in operating activities (120,595)(3,614)(124,209)
Cash flows from financing activities
Reduction of liability for sale of future royalties
(3,614)3,614 — 
Net cash (used in) provided by financing activities (757)3,614 2,857